BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31076252)

  • 21. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.
    Holme SA; Worwood M; Anstey AV; Elder GH; Badminton MN
    Blood; 2007 Dec; 110(12):4108-10. PubMed ID: 17804693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.
    Fratz EJ; Hunter GA; Ferreira GC
    PLoS One; 2014; 9(4):e93078. PubMed ID: 24718052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-linked dominant protoporphyria: The first reported Japanese case.
    Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
    J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse.
    Tian M; Campagna DR; Woodward LS; Justice MJ; Fleming MD
    Blood; 2008 Nov; 112(10):4308-13. PubMed ID: 18780836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
    Wang P; Sachar M; Lu J; Shehu AI; Zhu J; Chen J; Liu K; Anderson KE; Xie W; Gonzalez FJ; Klaassen CD; Ma X
    Sci Adv; 2019 Sep; 5(9):eaaw6127. PubMed ID: 31555729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
    Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
    J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
    Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
    Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.
    Fratz EJ; Clayton J; Hunter GA; Ducamp S; Breydo L; Uversky VN; Deybach JC; Gouya L; Puy H; Ferreira GC
    Biochemistry; 2015 Sep; 54(36):5617-31. PubMed ID: 26300302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
    Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
    Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
    Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
    Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of mRNA levels of delta-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice.
    Inafuku K; Takamiyagi A; Oshiro M; Kinjo T; Nakashima Y; Nonaka S
    J Dermatol Sci; 1999 Apr; 19(3):189-98. PubMed ID: 10215191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
    Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
    Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
    Sassa S; Schwartz S; Ruth G
    J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcytosis in Erythropoietic Protoporphyria.
    Graziadei G; Duca L; Granata F; De Luca G; De Giovanni A; Brancaleoni V; Nava I; Di Pierro E
    Front Physiol; 2022; 13():841050. PubMed ID: 35309058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
    Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
    Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy.
    Ventura P; Brancaleoni V; Di Pierro E; Graziadei G; Macrì A; Carmine Guida C; Nicolli A; Rossi MT; Granata F; Fiorentino V; Fustinoni S; Sala R; Pinton PC; Trevisan A; Marchini S; Cuoghi C; Marcacci M; Corradini E; Sorge F; Aurizi C; Savino MG; Cappellini MD; Pietrangelo A
    Eur J Dermatol; 2020 Oct; 30(5):532-540. PubMed ID: 33021473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.
    Cooperman SS; Meyron-Holtz EG; Olivierre-Wilson H; Ghosh MC; McConnell JP; Rouault TA
    Blood; 2005 Aug; 106(3):1084-91. PubMed ID: 15831703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.
    Hussain Z; Qi Q; Zhu J; Anderson KE; Ma X
    Pharmacol Ther; 2023 Aug; 248():108487. PubMed ID: 37392940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.